Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
Sponsor: Akero Therapeutics, Inc
Summary
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in cirrhotic subjects with biopsy-proven F4 compensated NASH.
Official title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
182
Start Date
2021-07-30
Completion Date
2025-05
Last Updated
2025-04-09
Healthy Volunteers
No
Conditions
Interventions
EFX
Investigational drug, Efruxifermin
Placebo
Placebo
Locations (49)
Akero Clinical Study Site
Chandler, Arizona, United States
Akero Clinical Study Site
Glendale, Arizona, United States
Akero Clinical Study Site
Tucson, Arizona, United States
Akero Clinical Study Site
Tucson, Arizona, United States
Akero Clinical Study Site
North Little Rock, Arkansas, United States
Akero Clinical Study Site
Fresno, California, United States
Akero Clinical Study Site
Long Beach, California, United States
Akero Clinical Study Site
Los Angeles, California, United States
Akero Clinical Study Site
Pasadena, California, United States
Akero Clinical Study Site
Englewood, Colorado, United States
Akero Clinical Study Site
Clearwater, Florida, United States
Akero Clinical Study Site
Fort Myers, Florida, United States
Akero Clinical Study Site
Fort Myers, Florida, United States
Akero Clinical Study Site
Hialeah Gardens, Florida, United States
Akero Clinical Study Site
Lakewood Rch, Florida, United States
Akero Clinical Study Site
Miami Lakes, Florida, United States
Akero Clinical Study Site
Ocala, Florida, United States
Akero Clinical Study Site
Sarasota, Florida, United States
Akero Clinical Study Site
South Bend, Indiana, United States
Akero Clinical Study Site
Topeka, Kansas, United States
Akero Clinical Study Site
Bastrop, Louisiana, United States
Akero Clinical Study Site
Marrero, Louisiana, United States
Akero Clinical Study Site
Las Vegas, Nevada, United States
Akero Clinical Study Site
Concord, North Carolina, United States
Akero Clinical Study Site
Fayetteville, North Carolina, United States
Akero Clinical Study Site
Morehead City, North Carolina, United States
Akero Clinical Study Site
Springboro, Ohio, United States
Akero Clinical Study Site
Westlake, Ohio, United States
Akero Clinical Study Site
Greenville, South Carolina, United States
Akero Clinical Study Site
Greenwood, South Carolina, United States
Akero Clinical Study Site
Summerville, South Carolina, United States
Akero Clinical Study Site
Nashville, Tennessee, United States
Akero Clinical Study Site
Austin, Texas, United States
Akero Clinical Study Site
Dallas, Texas, United States
Akero Clinical Study Site
Edinburg, Texas, United States
Akero Clinical Study Site
Edinburg, Texas, United States
Akero Clinical Study Site
Fort Worth, Texas, United States
Akero Clinical Study Site
Fort Worth, Texas, United States
Akero Clinical Study Site
Houston, Texas, United States
Akero Clinical Study Site
Houston, Texas, United States
Akero Clinical Study Site
San Antonio, Texas, United States
Akero Clinical Study Site
Waco, Texas, United States
Akero Clinical Study Site
Webster, Texas, United States
Akero Clinical Study Site
Wichita Falls, Texas, United States
Akero Clinical Study Site
Ogden, Utah, United States
Akero Clinical Study Site
Richmond, Virginia, United States
Akero Clinical Study Site
Mexico City, Mexico
Akero Clinical Study Site
Monterrey, Mexico
Akero Clinical Study Site
San Juan, Puerto Rico